At The Scripps Research Institute (TSRI), the world’s foremost scientists tackle the toughest health challenges. We seek cures and treatments for the most devastating diseases, including cancer, heart disease, diabetes, Alzheimer’s, Parkinson’s, and AIDS.
Additionally, TSRI’s graduate program has become one of the nation’s most prestigious centers for biomedical graduate education. It regularly appears in the top 10 graduate programs in both biology and chemistry in the U.S. News and World Report nationwide rankings.
However, TSRI is distinct from conventional academic institutions—providing faster commercialization of scientific discoveries, more rapid delivery of patient benefits, and a new model of biomedical research in America. Here’s how …
- Reaching Across Traditional Boundaries. Scientists at TSRI are characterized by independence from traditional boundaries, collaborating without the burden of excessive bureaucracy—which brings biomedical discoveries to patients more quickly and efficiently.
- Complementary Expertise. Each building on our campuses in California and Florida houses research labs of distinct and complementary expertise, ensuring that chemists and biologists intermingle with one another on a daily basis to facilitate the cross-fertilization of ideas. This versatility is distinct from traditional university environments that are too often saddled with historically divided departments and administrative structures that hinder creativity.
- State-of-the-Art Equipment. This collaboration is complemented by state-of-the-art robotics and chemical screening equipment and advanced computational capabilities, providing ever-shorter paths from discovery to application in the treatment of disease.
- Entrepreneurial Spirit. More than 50 companies have grown out of research and technology developed at TSRI or by TSRI faculty, and the institute’s annual licensing numbers are among the highest in the world for an organization of its size. More than 25 pharmaceuticals resulting from TSRI investigations and technology are currently in clinical development.
Breakthroughs made by TSRI investigators rank among the greatest achievements of science, changing the course of medicine at home and around the world. More than 2 million people have benefitted from drugs initially developed at the institute … and private philanthropy has led to an impressive list of research innovations.